Industry Research Reports

Home > Reports > Medical Care > Global Type 2 Diabetes Medicines Market Insights, Forecast to 2030

Global Type 2 Diabetes Medicines Market Insights, Forecast to 2030

Industry: Medical Care

Published: 2024-06-11

Pages: 149 Pages

Report ld: 2679593

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. The most common medicines used are insulin injection and oral hypoglycemic medications.

The global Type 2 Diabetes Medicines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes mainly from the food you eat.Insulin, ahormonemade by thepancreas, helps glucose get into your cells to be used for energy. In type 2 diabetes, your body doesn’t make enough insulin or doesn’t use insulin well. Too much glucose then stays in your blood, and not enough reaches your cells.Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes mainly from the food you eat. Insulin, a hormone made by the pancreas, helps glucose get into your cells to be used for energy. In type 2 diabetes, your body doesn’t make enough insulin or doesn’t use insulin well. Too much glucose then stays in your blood, and not enough reaches your cells.

Report Includes
This report presents an overview of global market for Type 2 Diabetes Medicines market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Type 2 Diabetes Medicines, also provides the revenue of main regions and countries. of the upcoming market potential for Type 2 Diabetes Medicines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Type 2 Diabetes Medicines revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Type 2 Diabetes Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Channel, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Type 2 Diabetes Medicines revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Type 2 Diabetes Medicines Market Insights, Forecast to 2030
Global Type 2 Diabetes Medicines Companies Covered
Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, United Pharmaceuticals, Ganli Pharmaceutical, Biocon, Conker Pharmaceuticals, Jiangsu Wanbang, Geropharm, Wockhardt, Merck Serono, Novartis
Global Type 2 Diabetes Medicines Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Type 2 Diabetes Medicines Market, Segment by Type
Oral Hypoglycemic Medications

Insulin Injection
Global Type 2 Diabetes Medicines Market, Segment by Application
Hospital

Retail Pharmacy
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Type 2 Diabetes Medicines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Type 2 Diabetes Medicines companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Channel and by country, revenue for each segment.
Chapter 7: Europe by Type, by Channel and by country, revenue for each segment.
Chapter 8: China by Type, and by Channel, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Channel and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Channel and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Type 2 Diabetes Medicines revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Type 2 Diabetes Medicines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Oral Hypoglycemic Medications
        1.2.3 Insulin Injection
    1.3 Market by Channel
        1.3.1 Global Type 2 Diabetes Medicines Market Share by Channel: 2019 VS 2023 VS 2030
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Type 2 Diabetes Medicines Market Perspective (2019-2030)
    2.2 Global Type 2 Diabetes Medicines Growth Trends by Region
        2.2.1 Global Type 2 Diabetes Medicines Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Type 2 Diabetes Medicines Historic Market Size by Region (2019-2024)
        2.2.3 Type 2 Diabetes Medicines Forecasted Market Size by Region (2025-2030)
    2.3 Type 2 Diabetes Medicines Market Dynamics
        2.3.1 Type 2 Diabetes Medicines Industry Trends
        2.3.2 Type 2 Diabetes Medicines Market Drivers
        2.3.3 Type 2 Diabetes Medicines Market Challenges
        2.3.4 Type 2 Diabetes Medicines Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Revenue Type 2 Diabetes Medicines by Players
        3.1.1 Global Type 2 Diabetes Medicines Revenue by Players (2019-2024)
        3.1.2 Global Type 2 Diabetes Medicines Revenue Market Share by Players (2019-2024)
    3.2 Global Type 2 Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Type 2 Diabetes Medicines, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Type 2 Diabetes Medicines Market Concentration Ratio
        3.4.1 Global Type 2 Diabetes Medicines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medicines Revenue in 2023
    3.5 Global Key Players of Type 2 Diabetes Medicines Head office and Area Served
    3.6 Global Key Players of Type 2 Diabetes Medicines, Product and Application
    3.7 Global Key Players of Type 2 Diabetes Medicines, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Type 2 Diabetes Medicines Breakdown Data by Type
    4.1 Global Type 2 Diabetes Medicines Historic Market Size by Type (2019-2024)
    4.2 Global Type 2 Diabetes Medicines Forecasted Market Size by Type (2025-2030)

 5 Type 2 Diabetes Medicines Breakdown Data by Channel
    5.1 Global Type 2 Diabetes Medicines Historic Market Size by Channel (2019-2024)
    5.2 Global Type 2 Diabetes Medicines Forecasted Market Size by Channel (2025-2030)

 6 North America
    6.1 North America Type 2 Diabetes Medicines Market Size (2019-2030)
    6.2 North America Type 2 Diabetes Medicines Market Size by Type
        6.2.1 North America Type 2 Diabetes Medicines Market Size by Type (2019-2024)
        6.2.2 North America Type 2 Diabetes Medicines Market Size by Type (2025-2030)
        6.2.3 North America Type 2 Diabetes Medicines Market Share by Type (2019-2030)
    6.3 North America Type 2 Diabetes Medicines Market Size by Channel
        6.3.1 North America Type 2 Diabetes Medicines Market Size by Channel (2019-2024)
        6.3.2 North America Type 2 Diabetes Medicines Market Size by Channel (2025-2030)
        6.3.3 North America Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
    6.4 North America Type 2 Diabetes Medicines Market Size by Country
        6.4.1 North America Type 2 Diabetes Medicines Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Type 2 Diabetes Medicines Market Size by Country (2019-2024)
        6.4.3 North America Type 2 Diabetes Medicines Market Share by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

 7 Europe
    7.1 Europe Type 2 Diabetes Medicines Market Size (2019-2030)
    7.2 Europe Type 2 Diabetes Medicines Market Size by Type
        7.2.1 Europe Type 2 Diabetes Medicines Market Size by Type (2019-2024)
        7.2.2 Europe Type 2 Diabetes Medicines Market Size by Type (2025-2030)
        7.2.3 Europe Type 2 Diabetes Medicines Market Share by Type (2019-2030)
    7.3 Europe Type 2 Diabetes Medicines Market Size by Channel
        7.3.1 Europe Type 2 Diabetes Medicines Market Size by Channel (2019-2024)
        7.3.2 Europe Type 2 Diabetes Medicines Market Size by Channel (2025-2030)
        7.3.3 Europe Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
    7.4 Europe Type 2 Diabetes Medicines Market Size by Country
        7.4.1 Europe Type 2 Diabetes Medicines Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Type 2 Diabetes Medicines Market Size by Country (2019-2024)
        7.4.3 Europe Type 2 Diabetes Medicines Market Size by Country (2025-2030)
        7.4.4 Germany
        7.4.5 France
        7.4.6 U.K.
        7.4.7 Italy
        7.4.8 Russia
        7.4.9 Nordic Countries

 8 China
    8.1 China Type 2 Diabetes Medicines Market Size (2019-2030)
    8.2 China Type 2 Diabetes Medicines Market Size by Type
        8.2.1 China Type 2 Diabetes Medicines Market Size by Type (2019-2024)
        8.2.2 China Type 2 Diabetes Medicines Market Size by Type (2025-2030)
        8.2.3 China Type 2 Diabetes Medicines Market Share by Type (2019-2030)
    8.3 China Type 2 Diabetes Medicines Market Size by Channel
        8.3.1 China Type 2 Diabetes Medicines Market Size by Channel (2019-2024)
        8.3.2 China Type 2 Diabetes Medicines Market Size by Channel (2025-2030)
        8.3.3 China Type 2 Diabetes Medicines Market Share by Channel (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Type 2 Diabetes Medicines Market Size (2019-2030)
    9.2 Asia Type 2 Diabetes Medicines Market Size by Type
        9.2.1 Asia Type 2 Diabetes Medicines Market Size by Type (2019-2024)
        9.2.2 Asia Type 2 Diabetes Medicines Market Size by Type (2025-2030)
        9.2.3 Asia Type 2 Diabetes Medicines Market Share by Type (2019-2030)
    9.3 Asia Type 2 Diabetes Medicines Market Size by Channel
        9.3.1 Asia Type 2 Diabetes Medicines Market Size by Channel (2019-2024)
        9.3.2 Asia Type 2 Diabetes Medicines Market Size by Channel (2025-2030)
        9.3.3 Asia Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
    9.4 Asia Type 2 Diabetes Medicines Market Size by Region
        9.4.1 Asia Type 2 Diabetes Medicines Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Type 2 Diabetes Medicines Market Size by Region (2019-2024)
        9.4.3 Asia Type 2 Diabetes Medicines Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

 10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Channel
        10.3.1 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Channel (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Channel (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
    10.4 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

 11 Key Players Profiles
    11.1 Novo Nordisk
        11.1.1 Novo Nordisk Company Details
        11.1.2 Novo Nordisk Business Overview
        11.1.3 Novo Nordisk Type 2 Diabetes Medicines Introduction
        11.1.4 Novo Nordisk Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.1.5 Novo Nordisk Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Type 2 Diabetes Medicines Introduction
        11.2.4 Sanofi Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.2.5 Sanofi Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Details
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Type 2 Diabetes Medicines Introduction
        11.3.4 Eli Lilly Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.3.5 Eli Lilly Recent Development
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Merck Business Overview
        11.4.3 Merck Type 2 Diabetes Medicines Introduction
        11.4.4 Merck Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.4.5 Merck Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Details
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca Type 2 Diabetes Medicines Introduction
        11.5.4 AstraZeneca Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.5.5 AstraZeneca Recent Development
    11.6 bayer
        11.6.1 bayer Company Details
        11.6.2 bayer Business Overview
        11.6.3 bayer Type 2 Diabetes Medicines Introduction
        11.6.4 bayer Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.6.5 bayer Recent Development
    11.7 Boehringer Ingelheim
        11.7.1 Boehringer Ingelheim Company Details
        11.7.2 Boehringer Ingelheim Business Overview
        11.7.3 Boehringer Ingelheim Type 2 Diabetes Medicines Introduction
        11.7.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.7.5 Boehringer Ingelheim Recent Development
    11.8 Johnson & Johnson
        11.8.1 Johnson & Johnson Company Details
        11.8.2 Johnson & Johnson Business Overview
        11.8.3 Johnson & Johnson Type 2 Diabetes Medicines Introduction
        11.8.4 Johnson & Johnson Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.8.5 Johnson & Johnson Recent Development
    11.9 Takeda
        11.9.1 Takeda Company Details
        11.9.2 Takeda Business Overview
        11.9.3 Takeda Type 2 Diabetes Medicines Introduction
        11.9.4 Takeda Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.9.5 Takeda Recent Development
    11.10 Tonghua Dongbao
        11.10.1 Tonghua Dongbao Company Details
        11.10.2 Tonghua Dongbao Business Overview
        11.10.3 Tonghua Dongbao Type 2 Diabetes Medicines Introduction
        11.10.4 Tonghua Dongbao Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.10.5 Tonghua Dongbao Recent Development
    11.11 United Pharmaceuticals
        11.11.1 United Pharmaceuticals Company Details
        11.11.2 United Pharmaceuticals Business Overview
        11.11.3 United Pharmaceuticals Type 2 Diabetes Medicines Introduction
        11.11.4 United Pharmaceuticals Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.11.5 United Pharmaceuticals Recent Development
    11.12 Ganli Pharmaceutical
        11.12.1 Ganli Pharmaceutical Company Details
        11.12.2 Ganli Pharmaceutical Business Overview
        11.12.3 Ganli Pharmaceutical Type 2 Diabetes Medicines Introduction
        11.12.4 Ganli Pharmaceutical Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.12.5 Ganli Pharmaceutical Recent Development
    11.13 Biocon
        11.13.1 Biocon Company Details
        11.13.2 Biocon Business Overview
        11.13.3 Biocon Type 2 Diabetes Medicines Introduction
        11.13.4 Biocon Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.13.5 Biocon Recent Development
    11.14 Conker Pharmaceuticals
        11.14.1 Conker Pharmaceuticals Company Details
        11.14.2 Conker Pharmaceuticals Business Overview
        11.14.3 Conker Pharmaceuticals Type 2 Diabetes Medicines Introduction
        11.14.4 Conker Pharmaceuticals Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.14.5 Conker Pharmaceuticals Recent Development
    11.15 Jiangsu Wanbang
        11.15.1 Jiangsu Wanbang Company Details
        11.15.2 Jiangsu Wanbang Business Overview
        11.15.3 Jiangsu Wanbang Type 2 Diabetes Medicines Introduction
        11.15.4 Jiangsu Wanbang Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.15.5 Jiangsu Wanbang Recent Development
    11.16 Geropharm
        11.16.1 Geropharm Company Details
        11.16.2 Geropharm Business Overview
        11.16.3 Geropharm Type 2 Diabetes Medicines Introduction
        11.16.4 Geropharm Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.16.5 Geropharm Recent Development
    11.17 Wockhardt
        11.17.1 Wockhardt Company Details
        11.17.2 Wockhardt Business Overview
        11.17.3 Wockhardt Type 2 Diabetes Medicines Introduction
        11.17.4 Wockhardt Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.17.5 Wockhardt Recent Development
    11.18 Merck Serono
        11.18.1 Merck Serono Company Details
        11.18.2 Merck Serono Business Overview
        11.18.3 Merck Serono Type 2 Diabetes Medicines Introduction
        11.18.4 Merck Serono Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.18.5 Merck Serono Recent Development
    11.19 Novartis
        11.19.1 Novartis Company Details
        11.19.2 Novartis Business Overview
        11.19.3 Novartis Type 2 Diabetes Medicines Introduction
        11.19.4 Novartis Revenue in Type 2 Diabetes Medicines Business (2019-2024)
        11.19.5 Novartis Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Type 2 Diabetes Medicines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Oral Hypoglycemic Medications
 Table 3. Key Players of Insulin Injection
 Table 4. Global Type 2 Diabetes Medicines Market Size Growth by Channel (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Type 2 Diabetes Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Type 2 Diabetes Medicines Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Type 2 Diabetes Medicines Market Share by Region (2019-2024)
 Table 8. Global Type 2 Diabetes Medicines Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Type 2 Diabetes Medicines Market Share by Region (2025-2030)
 Table 10. Type 2 Diabetes Medicines Market Trends
 Table 11. Type 2 Diabetes Medicines Market Drivers
 Table 12. Type 2 Diabetes Medicines Market Challenges
 Table 13. Type 2 Diabetes Medicines Market Restraints
 Table 14. Global Type 2 Diabetes Medicines Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Type 2 Diabetes Medicines Market Share by Players (2019-2024)
 Table 16. Global Top Type 2 Diabetes Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medicines as of 2023)
 Table 17. Global Type 2 Diabetes Medicines Industry Ranking 2022 VS 2023
 Table 18. Global 5 Largest Players Market Share by Type 2 Diabetes Medicines Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Type 2 Diabetes Medicines, Headquarters and Area Served
 Table 20. Global Key Players of Type 2 Diabetes Medicines, Product and Application
 Table 21. Global Key Players of Type 2 Diabetes Medicines, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Type 2 Diabetes Medicines Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Type 2 Diabetes Medicines Revenue Market Share by Type (2019-2024)
 Table 25. Global Type 2 Diabetes Medicines Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Type 2 Diabetes Medicines Revenue Market Share by Type (2025-2030)
 Table 27. Global Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (US$ Million)
 Table 28. Global Type 2 Diabetes Medicines Revenue Market Share by Channel (2019-2024)
 Table 29. Global Type 2 Diabetes Medicines Forecasted Market Size by Channel (2025-2030) & (US$ Million)
 Table 30. Global Type 2 Diabetes Medicines Revenue Market Share by Channel (2025-2030)
 Table 31. North America Type 2 Diabetes Medicines Market Size by Type (2019-2024) & (US$ Million)
 Table 32. North America Type 2 Diabetes Medicines Market Size by Type (2025-2030) & (US$ Million)
 Table 33. North America Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (US$ Million)
 Table 34. North America Type 2 Diabetes Medicines Market Size by Channel (2025-2030) & (US$ Million)
 Table 35. North America Type 2 Diabetes Medicines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Type 2 Diabetes Medicines Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Type 2 Diabetes Medicines Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Type 2 Diabetes Medicines Market Size by Type (2019-2024) & (US$ Million)
 Table 39. Europe Type 2 Diabetes Medicines Market Size by Type (2025-2030) & (US$ Million)
 Table 40. Europe Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (US$ Million)
 Table 41. Europe Type 2 Diabetes Medicines Market Size by Channel (2025-2030) & (US$ Million)
 Table 42. Europe Type 2 Diabetes Medicines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Europe Type 2 Diabetes Medicines Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Europe Type 2 Diabetes Medicines Market Size by Country (2025-2030) & (US$ Million)
 Table 45. China Type 2 Diabetes Medicines Market Size by Type (2019-2024) & (US$ Million)
 Table 46. China Type 2 Diabetes Medicines Market Size by Type (2025-2030) & (US$ Million)
 Table 47. China Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (US$ Million)
 Table 48. China Type 2 Diabetes Medicines Market Size by Channel (2025-2030) & (US$ Million)
 Table 49. Asia Type 2 Diabetes Medicines Market Size by Type (2019-2024) & (US$ Million)
 Table 50. Asia Type 2 Diabetes Medicines Market Size by Type (2025-2030) & (US$ Million)
 Table 51. Asia Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (US$ Million)
 Table 52. Asia Type 2 Diabetes Medicines Market Size by Channel (2025-2030) & (US$ Million)
 Table 53. Asia Type 2 Diabetes Medicines Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 54. Asia Type 2 Diabetes Medicines Market Size by Region (2019-2024) & (US$ Million)
 Table 55. Asia Type 2 Diabetes Medicines Market Size by Region (2025-2030) & (US$ Million)
 Table 56. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Type (2019-2024) & (US$ Million)
 Table 57. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Type (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Channel (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 61. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Country (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size by Country (2025-2030) & (US$ Million)
 Table 63. Novo Nordisk Company Details
 Table 64. Novo Nordisk Business Overview
 Table 65. Novo Nordisk Type 2 Diabetes Medicines Product
 Table 66. Novo Nordisk Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 67. Novo Nordisk Recent Development
 Table 68. Sanofi Company Details
 Table 69. Sanofi Business Overview
 Table 70. Sanofi Type 2 Diabetes Medicines Product
 Table 71. Sanofi Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 72. Sanofi Recent Development
 Table 73. Eli Lilly Company Details
 Table 74. Eli Lilly Business Overview
 Table 75. Eli Lilly Type 2 Diabetes Medicines Product
 Table 76. Eli Lilly Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 77. Eli Lilly Recent Development
 Table 78. Merck Company Details
 Table 79. Merck Business Overview
 Table 80. Merck Type 2 Diabetes Medicines Product
 Table 81. Merck Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 82. Merck Recent Development
 Table 83. AstraZeneca Company Details
 Table 84. AstraZeneca Business Overview
 Table 85. AstraZeneca Type 2 Diabetes Medicines Product
 Table 86. AstraZeneca Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 87. AstraZeneca Recent Development
 Table 88. bayer Company Details
 Table 89. bayer Business Overview
 Table 90. bayer Type 2 Diabetes Medicines Product
 Table 91. bayer Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 92. bayer Recent Development
 Table 93. Boehringer Ingelheim Company Details
 Table 94. Boehringer Ingelheim Business Overview
 Table 95. Boehringer Ingelheim Type 2 Diabetes Medicines Product
 Table 96. Boehringer Ingelheim Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 97. Boehringer Ingelheim Recent Development
 Table 98. Johnson & Johnson Company Details
 Table 99. Johnson & Johnson Business Overview
 Table 100. Johnson & Johnson Type 2 Diabetes Medicines Product
 Table 101. Johnson & Johnson Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 102. Johnson & Johnson Recent Development
 Table 103. Takeda Company Details
 Table 104. Takeda Business Overview
 Table 105. Takeda Type 2 Diabetes Medicines Product
 Table 106. Takeda Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 107. Takeda Recent Development
 Table 108. Tonghua Dongbao Company Details
 Table 109. Tonghua Dongbao Business Overview
 Table 110. Tonghua Dongbao Type 2 Diabetes Medicines Product
 Table 111. Tonghua Dongbao Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 112. Tonghua Dongbao Recent Development
 Table 113. United Pharmaceuticals Company Details
 Table 114. United Pharmaceuticals Business Overview
 Table 115. United Pharmaceuticals Type 2 Diabetes Medicines Product
 Table 116. United Pharmaceuticals Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 117. United Pharmaceuticals Recent Development
 Table 118. Ganli Pharmaceutical Company Details
 Table 119. Ganli Pharmaceutical Business Overview
 Table 120. Ganli Pharmaceutical Type 2 Diabetes Medicines Product
 Table 121. Ganli Pharmaceutical Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 122. Ganli Pharmaceutical Recent Development
 Table 123. Biocon Company Details
 Table 124. Biocon Business Overview
 Table 125. Biocon Type 2 Diabetes Medicines Product
 Table 126. Biocon Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 127. Biocon Recent Development
 Table 128. Conker Pharmaceuticals Company Details
 Table 129. Conker Pharmaceuticals Business Overview
 Table 130. Conker Pharmaceuticals Type 2 Diabetes Medicines Product
 Table 131. Conker Pharmaceuticals Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 132. Conker Pharmaceuticals Recent Development
 Table 133. Jiangsu Wanbang Company Details
 Table 134. Jiangsu Wanbang Business Overview
 Table 135. Jiangsu Wanbang Type 2 Diabetes Medicines Product
 Table 136. Jiangsu Wanbang Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 137. Jiangsu Wanbang Recent Development
 Table 138. Geropharm Company Details
 Table 139. Geropharm Business Overview
 Table 140. Geropharm Type 2 Diabetes Medicines Product
 Table 141. Geropharm Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 142. Geropharm Recent Development
 Table 143. Wockhardt Company Details
 Table 144. Wockhardt Business Overview
 Table 145. Wockhardt Type 2 Diabetes Medicines Product
 Table 146. Wockhardt Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 147. Wockhardt Recent Development
 Table 148. Merck Serono Company Details
 Table 149. Merck Serono Business Overview
 Table 150. Merck Serono Type 2 Diabetes Medicines Product
 Table 151. Merck Serono Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 152. Merck Serono Recent Development
 Table 153. Novartis Company Details
 Table 154. Novartis Business Overview
 Table 155. Novartis Type 2 Diabetes Medicines Product
 Table 156. Novartis Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)
 Table 157. Novartis Recent Development
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Type 2 Diabetes Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Type 2 Diabetes Medicines Market Share by Type: 2023 VS 2030
 Figure 3. Oral Hypoglycemic Medications Features
 Figure 4. Insulin Injection Features
 Figure 5. Global Type 2 Diabetes Medicines Market Size Growth Rate by Channel, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 6. Global Type 2 Diabetes Medicines Market Share by Channel: 2023 VS 2030
 Figure 7. Hospital Case Studies
 Figure 8. Retail Pharmacy Case Studies
 Figure 9. Type 2 Diabetes Medicines Report Years Considered
 Figure 10. Global Type 2 Diabetes Medicines Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 11. Global Type 2 Diabetes Medicines Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Type 2 Diabetes Medicines Market Share by Region: 2023 VS 2030
 Figure 13. Global Type 2 Diabetes Medicines Market Share by Players in 2023
 Figure 14. Global Top Type 2 Diabetes Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medicines as of 2023)
 Figure 15. The Top 10 and 5 Players Market Share by Type 2 Diabetes Medicines Revenue in 2023
 Figure 16. North America Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 17. North America Type 2 Diabetes Medicines Market Share by Type (2019-2030)
 Figure 18. North America Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
 Figure 19. North America Type 2 Diabetes Medicines Market Share by Country (2019-2030)
 Figure 20. United States Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Type 2 Diabetes Medicines Market Share by Type (2019-2030)
 Figure 24. Europe Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
 Figure 25. Europe Type 2 Diabetes Medicines Market Share by Country (2019-2030)
 Figure 26. Germany Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. China Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. China Type 2 Diabetes Medicines Market Share by Type (2019-2030)
 Figure 34. China Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
 Figure 35. Asia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Asia Type 2 Diabetes Medicines Market Share by Type (2019-2030)
 Figure 37. Asia Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
 Figure 38. Asia Type 2 Diabetes Medicines Market Share by Region (2019-2030)
 Figure 39. Japan Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. South Korea Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. India Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Australia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Share by Type (2019-2030)
 Figure 47. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Share by Channel (2019-2030)
 Figure 48. Middle East, Africa, and Latin America Type 2 Diabetes Medicines Market Share by Country (2019-2030)
 Figure 49. Brazil Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Mexico Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Turkey Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Israel Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. GCC Countries Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 56. Sanofi Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 57. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 58. Merck Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 59. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 60. bayer Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 61. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 62. Johnson & Johnson Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 63. Takeda Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 64. Tonghua Dongbao Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 65. United Pharmaceuticals Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 66. Ganli Pharmaceutical Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 67. Biocon Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 68. Conker Pharmaceuticals Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 69. Jiangsu Wanbang Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 70. Geropharm Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 71. Wockhardt Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 72. Merck Serono Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 73. Novartis Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. The most common medicines used are insulin injection and oral hypoglycemic medications.

The global Type 2 Diabetes Medicines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

Descriptive company profiles of the major global players, including Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.

Market Segmentation